AAD 2023 SPEAKER INTERVIEWS

Expert Perspectives in Atopic Dermatitis

Dr. Silverberg discusses how to safely counsel patients when deciding between topical versus oral JAK inhibitors for the treatment of atopic dermatitis.

In this series, board-certified dermatologists discuss new and emerging treatments for patients with vitiligo.

In this series, experts in atopic dermatitis discuss new JAK inhibitors for the treatment of AD.

In this four-video series, experts in the field of medical dermatology discuss current and new treatment options for psoriasis and vitiligo.

In this series, board-certified dermatologists review published articles covering various topics such as hair growth, psoriasis, vitiligo, and aesthetics.

FEATURED VIDEOS

Dr. Harper recaps her session from Maui Derm NP+PA Fall, in which she discussed moving away from rosacea subtypes as well as new insights in rosacea pathogenesis and treatment.

POPULAR ON JCADTV

Expert Perspectives in Atopic Dermatitis

Natural Hair Supplements: Trends and Myths Untangled

Andrew Blauvelt, MD, MBA, a dermatologist at the Oregon Medical Research Center in Portland, Oregon, discusses the impact Ruxolitinib cream has on itch in patients with atopic dermatitis which has been a predominant issue in disease symptoms.
Nanette Silverberg, MD, a Clinical Professor of Pediatrics and Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York, provides an overview of an article from the Journal of Drugs in Dermatology regarding the use
Linda Stein Gold, MD, discusses an article published in the Journal of Drugs in Dermatology titled, "Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy."

MORE FEATURED VIDEOS